Boston Scientific Corp
BSX- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000885725
In the last 90 days, Boston Scientific Corp insiders filed 5 open-market purchases and 0 sales; 1,487 institutions reported holding it in 13F filings for Q2 2026, worth $57.3B in total; Maverick Capital is the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Boston Scientific Corp changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 1,000 | 1 | 1,069 | +70 |
| Shares | 1.31B | 521 | 1.32B | +11.1M (+0.8%) |
| Value | $65.7B | $26.0K | $71.6B | +$5.88B (+8.9%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (134)
Institutions that held Boston Scientific Corp at the end of Q2 2023 but not at the end of Q1 2023.
Showing the largest 100 of 134 by value.
Sold out (64)
Institutions that held Boston Scientific Corp at the end of Q1 2023 and filed for Q2 2023 without it.
Not filed for Q2 2023 yet (1)
Institutions that held Boston Scientific Corp at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Householder Group Estate & Retirement Specialist, LLC | 521 | $26.0K |